Both in Biotechnology
Tevogen vs Atara Biotherapeutics
Over the past year TVGN returned −79.7% and ATRA returned −37.8%; their daily moves had a correlation of -0.02.
TVGN −79.7% ATRA −37.8%Growth of $1, one year, split-adjusted
| Metric | TVGN | ATRA |
|---|---|---|
| Price | $5.97 | $8.62 |
| Market cap | $93.9M | $86.5M |
| Today | +6.80% | +1.65% |
| 1 month | −9.5% | −8.3% |
| 6 months | −19.0% | +81.1% |
| Year to date | −63.9% | −52.3% |
| 1 year | — | −42.0% |
| Revenue growth (YoY) | — | −96.4% |
| Gross margin | — | 69.7% |
| Net margin | — | −767.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 14.0× |
| Net cash | -$7.0M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 65.2% |
| Short % of float | 3.9% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).